Georgian Med News
April 2023
The goal is to establish serological invasive markers of Chlamydia trachomatis in female prisoners and to analyse the risk factors for the spread of chlamydial infection in prisons in Ukraine. When studying a sample of 103 female prisoners (whose average age is 35.9 years), serological markers of Chlamydia trachomatis (immunoglobulin G) were analysed.
View Article and Find Full Text PDFIn the presence of numerous trigger factors contributing to the exposure of allergodermathosis, there is significant heterogeneity in the phenotypic manifestations of the disease, the severity of its course, as well as the co-morbidity and response to therapy. Objective - to assess the possibility of predicting the severity of allergodermathosis complicated by staphylococcal infection, taking into account the patients' clinical and medical history, bacteriological and immunological indicators. The study included 252 patients with allergodermathosis (95 with atopic dermatitis (AD) and 157 with true eczema (TE)), who were admitted for treatment to the Department of Dermatology of the SE "Institute of Dermatology and Venerology of the National Academy of Medical Sciences of Ukraine" in 2016 - 2019.
View Article and Find Full Text PDFThe development of atopic dermatitis (AD) is often associated with the presence of pathogenic microflora in the skin's biotope against the background of acute immunological disorders of the microorganism. In this case, the leading role is played by Staphylococcus aureus, which is seeded in 80-95% of patients diagnosed with AD. The clinical significance of the pathogen is determined by its ability to actively survive in the biotope, aided by a wide range of pathogenicity factors of this microorganism.
View Article and Find Full Text PDFObjective: To evaluate the efficacy of cytoflavin in the treatment of hypoxic-ischemic lesions of the nervous system in young infants with transient neonatal hypothyroidism.
Material And Methods: Authors analyzed the efficacy of cytoflavin in the treatment of cerebral ischemia in the combination with transient neonatal hypothyroidism in 89 newborns. The main group comprised 43 children treated with intravenous cytoflavin in dose 2 ml per 1 kg of body weight per day for five days; 46 newborns of the comparison group received basic therapy.